Thain Lin Koh currently works at Amplogix Technology Sdn. Bhd., as Executive Director, Cabnet Holdings Bhd., as Executive Director from 2025, Advancenet Technology Sdn. Bhd., as Senior Product ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the US to start to recover once a ban on compound copycats is enforced this month, its CEO said today after the company cut its 2025 ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp decline ...

Novo Nordisk is scheduled to report results for the first quarter on Wednesday. Here is what to know: NET PROFIT FORECAST: Net profit is expected to rise 11% to 28.08 billion Danish kroner ($4.26 ...

Novo Nordisk NOVO.B0.70%increase; green up pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense ...

(This May 5 story has been corrected to say that the planned transaction to raise Volvo Cars stake in Novo Energy to 100% from 50% is still pending approval, in paragraph 9) STOCKHOLM (Reuters ...

[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday (May 7) it would drop gender representation requirements for its US business following executive orders by President Donald Trump to stop ...

This happened on April 9, 2025. Novo Nordisk warned about these fake drugs. Elon Musk mentioned using a similar drug. The FDA is investigating the seized injections. Novo Nordisk won a legal ...

Without effective interventions, the global burden of obesity and its complications will continue to rise,” said Stephen Gough, senior vice president and head of Chief Medical Office at Novo Nordisk. ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of Hims & Hers Health, LifeMD, and Ro to drive direct-to-consumer sales of ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.